Abstract: An assembly and a method for affixing an assembly to a structure. The assembly includes a bracket and an accessory. The bracket includes two or more bracket retainers and a bracket lock extending into an opening formed in the bracket. The accessory includes two or more accessory retainers, and an accessory lock. The two or more accessory retainers define receiving features, which accept the two or more bracket retainers when the accessory is in an engaged position with the bracket. The accessory has a sliding engagement with the bracket, from the engaged position to a locked position, in which the bracket lock engages with the accessory lock.

Abstract: An assembly and a method for affixing an assembly to a structure. The assembly includes a bracket and an accessory. The bracket includes two or more bracket retainers and a bracket lock extending into an opening formed in the bracket. The accessory includes two or more accessory retainers, and an accessory lock. The two or more accessory retainers define receiving features, which accept the two or more bracket retainers when the accessory is in an engaged position with the bracket. The accessory has a sliding engagement with the bracket, from the engaged position to a locked position, in which the bracket lock engages with the accessory lock.

Abstract: Various embodiments provide systems, methods, devices, and instructions for performing simultaneous localization and mapping (SLAM) that involve initializing a SLAM process using images from as few as two different poses of a camera within a physical environment. Some embodiments may achieve this by disregarding errors in matching corresponding features depicted in image frames captured by an image sensor of a mobile computing device, and by updating the SLAM process in a way that causes the minimization process to converge to global minima rather than fall into a local minimum.

Abstract: The present invention relates, generally, to improved methods of delivering a biologically active agent, in particular a therapeutic or prophylactic nucleic acid, to the ocular sphere of a subject comprising administering said agent to the ciliary body tissue(s) or cells and/or to the extra-ocular muscle tissue or cells. More particularly, the invention relates to devices, their uses, notably in gene therapy, and to methods for treating pathologies of the ocular sphere by specific ciliary body tissue(s) or cells and/or extra-ocular muscle or cells administration of a therapeutic product and transfer thereof into the ocular tissue to be treated. This invention also relates to pharmaceutical compositions comprising the product in a form suitable for ciliary body tissue(s) or cells and/or extra-ocular muscle or cells administration, their preparation and uses.

Abstract: The present invention relates, generally, to improved methods of delivering a biologically active agent, in particular a therapeutic or prophylactic nucleic acid, to the ocular sphere of a subject comprising administering said agent to the ciliary body tissue(s) or cells and/or to the extra-ocular muscle tissue or cells. More particularly, the invention relates to devices, their uses, notably in gene therapy, and to methods for treating pathologies of the ocular sphere by specific ciliary body tissue(s) or cells and/or extra-ocular muscle or cells administration of a therapeutic product and transfer thereof into the ocular tissue to be treated. This invention also relates to pharmaceutical compositions comprising the product in a form suitable for ciliary body tissue(s) or cells and/or extra-ocular muscle or cells administration, their preparation and uses.